Vycor Medical (VYCO) Change in Receivables (2010 - 2026)
Vycor Medical's (VYCO) quarterly Change in Receivables came in at -$16510.0 in Q1 2026, down 4.19% year-on-year from -$17232.1 in Q1 2025, and up 84.59% on a QoQ basis from -$107161.0 in Q4 2025.
Vycor Medical (VYCO) Change in Receivables (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has 17 years of Change in Receivables data on file, last reported at -$16510.0 in Q1 2026.
- On a quarterly basis, Change in Receivables fell 4.19% year-over-year to -$16510.0 in Q1 2026; TTM through Mar 2026 was -$24342.0, a 50.77% decrease from a year earlier, with the FY2025 full-year figure at -$23678.0, down 170.88% from the prior year.
- Change in Receivables for Q1 2026 stood at -$16510.0, up from -$107161.0 in the prior quarter.
- Over the last five years, Change in Receivables for VYCO reached as high as $126074.0 in Q3 2025 and fell as low as -$107161.0 in Q4 2025.
- Historically, Change in Receivables has averaged $4844.2 across 5 years, with a median of -$15566.0 in 2024.
- On a YoY basis, Change in Receivables climbed as much as 909.93% in 2025 and fell as far as 1733.55% in 2025.
- Year by year, Change in Receivables stood at -$24354.0 in 2022, then plunged by 64.39% to -$40035.0 in 2023, then jumped by 116.39% to $6560.0 in 2024, then slumped by 1733.55% to -$107161.0 in 2025, then jumped by 84.59% to -$16510.0 in 2026.
- Per Business Quant data, the three most recent Change in Receivables figures were -$16510.0 in Q1 2026, -$107161.0 in Q4 2025, and $126074.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Vycor Medical | 2.34 Mn | 2.16 Mn | 375,153.00 | -16,510.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16,510.00 |
| Mar 31, 2026 | -16,510.00 |
| Dec 31, 2025 | -107,161.00 |
| Dec 31, 2025 | -107,161.00 |
| Sep 30, 2025 | 126,074.00 |
| Sep 30, 2025 | 126,074.00 |
| Jun 30, 2025 | -26,745.00 |
| Jun 30, 2025 | -26,745.00 |
| Mar 31, 2025 | -15,846.00 |
| Mar 31, 2025 | -15,846.00 |
| Dec 31, 2024 | 6,560.00 |
| Dec 31, 2024 | 6,560.00 |
| Sep 30, 2024 | -15,566.00 |
| Sep 30, 2024 | -15,566.00 |
| Jun 30, 2024 | 8,707.00 |
| Jun 30, 2024 | 8,707.00 |
| Mar 31, 2024 | 33,703.00 |
| Mar 31, 2024 | 33,703.00 |
| Dec 31, 2023 | -40,035.00 |
| Dec 31, 2023 | -40,035.00 |